Raymond James Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $128.00

Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective trimmed by Raymond James from $138.00 to $128.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the medical equipment provider’s stock. Several other brokerages also recently weighed in on ZBH. Evercore ISI lowered their […]

Leave a Reply

Your email address will not be published.

Previous post Shutterstock (NYSE:SSTK) Announces Quarterly Earnings Results
Next post SATS Self Reported Market Capitalization Achieves $550.80 Million (1000SATS)